Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
2.
Cureus ; 15(7): e41552, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37554622

ABSTRACT

Transfusion-related acute lung injury (TRALI) is an acute respiratory distress syndrome (ARDS) occurring during or within six hours after transfusion. On the other hand, while inhaled nitric oxide (iNO) temporarily improves arterial oxygenation with selective pulmonary vasodilation, there is no evidence of mortality reduction in ARDS. We herein report a case in which TRALI was diagnosed with severe hypoxemia during cardiovascular surgery, and extracorporeal membrane oxygenation (ECMO) was avoided by using iNO for respiratory management. Administering iNO to patients with acute respiratory failure may be useful as a bridging therapy to help patients recover. However, further evidence is needed before this treatment can become standard practise.

3.
Cureus ; 14(8): e28366, 2022 Aug.
Article in English | MEDLINE | ID: mdl-36171853

ABSTRACT

Pseudothrombocytopenia (PTCP) is a phenomenon in which platelet aggregation occurs in vitro when an anticoagulant such as ethylenediaminetetraacetic acid (EDTA) is used in a blood sample, causing automated cell counters (ACC) to calculate a lower platelet count than the actual count. While a peripheral blood smear is required to assess platelet count in PTCP accurately, such a time-consuming test is not accessible during the perioperative period. In this study, we evaluated platelet function using thromboelastography (TEG) for a patient with PTCP requiring cardiac reoperation. The preoperative TEG value of the patient was within the normal range, suggesting that TEG for PTCP reflects platelet function more accurately than ACC. Since there is an insufficient number of case reports on the use of TEG for PTCP, it is necessary to consider its usefulness not only during the perioperative period but also for other critical care.

4.
JACS Au ; 1(4): 375-379, 2021 Apr 26.
Article in English | MEDLINE | ID: mdl-34467302

ABSTRACT

A strategy to obtain chiral silica using an achiral stereoregular polymer with polyhedral oligomeric silsesquioxane (POSS) side chains is described herein. The preferred helical conformation of the POSS-containing polymer could be achieved by mixing isotactic polymethacrylate-functionalized POSS (it-PMAPOSS) and a chiral dopant. The array structure of POSS molecules, which are placed along the helical conformation, is memorized even after removing the chiral dopant at high temperatures, leading to a chiral silica compound with exclusive optical activity after calcination.

5.
Immunity ; 49(1): 56-65.e4, 2018 07 17.
Article in English | MEDLINE | ID: mdl-29958799

ABSTRACT

Potassium (K+) efflux across the plasma membrane is thought to be an essential mechanism for ATP-induced NLRP3 inflammasome activation, yet the identity of the efflux channel has remained elusive. Here we identified the two-pore domain K+ channel (K2P) TWIK2 as the K+ efflux channel triggering NLRP3 inflammasome activation. Deletion of Kcnk6 (encoding TWIK2) prevented NLRP3 activation in macrophages and suppressed sepsis-induced lung inflammation. Adoptive transfer of Kcnk6-/- macrophages into mouse airways after macrophage depletion also prevented inflammatory lung injury. The K+ efflux channel TWIK2 in macrophages has a fundamental role in activating the NLRP3 inflammasome and consequently mediates inflammation, pointing to TWIK2 as a potential target for anti-inflammatory therapies.


Subject(s)
Inflammasomes/metabolism , Inflammation/physiopathology , Macrophages/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Potassium Channels, Tandem Pore Domain/metabolism , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Animals , Caspase 1/deficiency , Caspase 1/metabolism , Cell Line , Inflammasomes/drug effects , Interleukin-1beta/metabolism , Lipopolysaccharides/pharmacology , Lung Injury/metabolism , Lung Injury/physiopathology , Macrophages/transplantation , Mice, Inbred C57BL , Mice, Knockout , NLR Family, Pyrin Domain-Containing 3 Protein/deficiency , Potassium Channels/drug effects , Potassium Channels/metabolism , Potassium Channels, Tandem Pore Domain/antagonists & inhibitors , Potassium Channels, Tandem Pore Domain/deficiency , Quinine/pharmacology , RNA, Small Interfering/pharmacology , Receptors, Purinergic P2X7/deficiency , Receptors, Purinergic P2X7/metabolism , Sepsis/metabolism , Sepsis/physiopathology , Signal Transduction/drug effects
6.
Biochem J ; 411(3): 623-31, 2008 May 01.
Article in English | MEDLINE | ID: mdl-18237272

ABSTRACT

Clinical relevance is implicated between the genetic polymorphisms of the ABC (ATP-binding cassette) transporter ABCG2 (ABC subfamily G, member 2) and the individual differences in drug response. We expressed a total of seven non-synonymous SNP (single nucleotide polymorphism) variants in Flp-In-293 cells by using the Flp (flippase) recombinase system. Of these, ABCG2 F208S and S441N variants were found to be expressed at markedly low levels, whereas their mRNA levels were equal to those of the other SNP variants and ABCG2 WT (wild-type). Interestingly, protein expression levels of the ABCG2 F208S and S441N variants increased 6- to 12-fold when Flp-In-293 cells were treated with MG132, a proteasome inhibitor. Immunoprecipitation followed by immunoblot analysis showed that the ABCG2 F208S and S441N variant proteins were endogenously ubiquitinated in Flp-In-293 cells, and treatment with MG132 significantly enhanced the level of these ubiquitinated variants. Immunofluorescence microscopy demonstrated that MG132 greatly affected the ABCG2 F208S and S441N variants in terms of both protein levels and intracellular distribution. Immunoblot analysis revealed that those variants were N-glycosylated; however, their oligosaccharides were immature compared with those present on ABCG2 WT. The ABCG2 F208S and S441N variant proteins do not appear to be processed in the Golgi apparatus, but undergo ubiquitin-mediated protein degradation in proteasomes, whereas ABCG2 WT is sorted to the plasma membrane and then degraded via the lysosomal pathway. The present study provides the first evidence that certain genetic polymorphisms can affect the protein stability of ABCG2. Control of proteasomal degradation of ABCG2 would provide a novel approach in cancer chemotherapy to circumvent multidrug resistance of human cancers.


Subject(s)
ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Polymorphism, Single Nucleotide/genetics , Proteasome Endopeptidase Complex/metabolism , Ubiquitin/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2 , Cell Line , Gene Expression Regulation/drug effects , Glycosylation/drug effects , Humans , Leupeptins/pharmacology , Macrolides/pharmacology
7.
Drug Metab Pharmacokinet ; 22(6): 428-40, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18159130

ABSTRACT

Since porphyrins are regarded as endogenous substrates for the ATP-binding cassette (ABC) transporter ABCG2, it is hypothesized that functional impairment owing to genetic polymorphisms or inhibition of ABCG2 by drugs may result in a disruption of cellular porphyrin homeostasis. In the present study, we expressed ABCG2 genetic variants, i.e., V12M, Q141K, S441N, and F489L, as well as the wild type (WT) in Flp-In-293 cells to examine the hypothesis. Cells expressing S441N and F489L variants exhibited high levels of both cellularly accumulated pheophorbide a and photosensitivity, when those cells were incubated with pheophorbide a and irradiated with visible light. To further elucidate the significance of ABCG2 in cellular porphyrin homeostasis, we observed cellular accumulation and compartmentation of porphyrin and pheophorbide a by means of a new fluorescence microscopy technology, and found that accumulation of porphyrin and pheophorbide a in the cytoplasm compartment was maintained at low levels in Flp-In-293 cells expressing ABCG2 WT, V12M, or Q141K. When ABCG2 was inhibited by imatinib or novobiocin, however, those cells became sensitive to light. Based on these results, it is strongly suggested that certain genetic polymorphisms and/or inhibition of ABCG2 by drugs can enhance the potential risk of photosensitivity.


Subject(s)
ATP-Binding Cassette Transporters/metabolism , Light , Membrane Transport Modulators/toxicity , Neoplasm Proteins/metabolism , Photosensitivity Disorders/etiology , Photosensitizing Agents/toxicity , Polymorphism, Single Nucleotide , Porphyrins/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2 , ATP-Binding Cassette Transporters/antagonists & inhibitors , ATP-Binding Cassette Transporters/genetics , Animals , Benzamides , Cell Line , Cell Survival/drug effects , Cell Survival/radiation effects , Chlorophyll/analogs & derivatives , Chlorophyll/toxicity , Dose-Response Relationship, Drug , Drug Interactions , Homeostasis , Humans , Imatinib Mesylate , Inhibitory Concentration 50 , Insecta , Microscopy, Fluorescence , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , Novobiocin/toxicity , Photosensitivity Disorders/chemically induced , Photosensitivity Disorders/genetics , Photosensitivity Disorders/metabolism , Photosensitizing Agents/metabolism , Piperazines/toxicity , Pyrimidines/toxicity , Quercetin/pharmacology , Quercetin/toxicity , Risk Assessment , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...